Shilpa Medicare received US Food and Drug Administration (USFDA) tentative popularity of its ANDA, Tenofovir Alafenamide Tablets, 25 mg on 15 Sep 2022. The ANDA become filed as ‘First to File’ submission on NCE -1 date.
Tenofovir Alafenamide Tablets, 25 mg is a typical equal of reference listed drug (RLD) Vemlidy capsules, of Gilead Sciences Inc. Used in the treatment of persistent hepatitis B virus infection as encouraged inside the label authorised with the aid of FDA.
According to IQVIA MAT Q2 2022 information, the United States marketplace for Tenofovir Alafenamide Tablets, 25 mg is approximately US$ 498.14 Million.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
